NeuroPath AI is the first MedCore product.
Our product line starts with acute stroke decision-support workflows and grows on top of the same secure medical AI infrastructure stack MedCore builds for institutions and partners.
01
First product
NeuroPath AI
05
Core flow
Input, imaging, guideline filter, ML estimation, report
MD
Clinical role
Decision support, not physician replacement
First clinical use case
Acute ischemic stroke decision support
NeuroPath AI starts with acute stroke decision-support workflows that combine clinical data, imaging inputs, guideline logic and ML-based estimation to support decisions under time pressure.
Why this product
Built for the hardest moments in stroke pathways
Stroke decisions are time-critical, risk-sensitive and often inconsistent across environments. NeuroPath AI is meant to support teams with a more structured decision flow.
Clinical challenge
- Time-critical stroke pathways where delayed decisions change outcome
- Benefit versus hemorrhagic-risk tradeoffs in complex cases
- Workflow fragmentation between clinical data, imaging and local infrastructure
Product approach
- Integrates clinical and imaging data into one workflow
- Uses deterministic guideline filtering before ML estimation
- Produces a decision-support report while keeping clinicians in control
How it works
The NeuroPath AI product flow
The product direction starts with an acute stroke workflow and keeps NeuroPath AI as the public product name.
01
Patient data input
Clinical context is captured first so the product starts from the real care situation.
02
Imaging import
CCT, CTA and CTP inputs are brought into the same decision flow.
03
Guideline filter
Deterministic logic applies guideline-based constraints before probabilistic scoring.
04
ML outcome estimation
Machine learning estimates support case review without becoming the final decision maker.
05
Decision report generation
The output is structured for review, discussion and accountable use in the workflow.
Current product stage
Product validation direction
NeuroPath AI is the first MedCore product and is currently framed for clinical validation planning before production clinical use.
- Built around acute stroke decision-support workflows under the NeuroPath AI product
- Project material references a research dataset of 1,200 synthetic patients
- Guideline filtering is aligned with AHA/ASA 2023 decision logic in the product direction
- The product is framed for supervised evaluation and clinical validation planning
- The design principle remains physician support, not physician replacement
Beyond the first product
What Products means for MedCore
This is where MedCore software grows. NeuroPath AI comes first, with later tools able to use the same infrastructure, governance and deployment model.
NeuroPath AI first
Stroke decision support is the first software product in the MedCore portfolio.
Healthcare workflow expansion
Future products can target additional clinical, operational or diagnostic workflows.
One shared stack
Every product can reuse the same private infrastructure, governance layer and deployment model.